ViAqua Therapeutics: Funding, Investors & Team (Sep 2026)
ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotech experience.
ViAqua Therapeutics has raised $4.3M across 1 funding round on record, the most recent an undisclosed round of $4.3M announced in Jun 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ViAqua Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
ViAqua Therapeutics Funding Rounds
ViAqua Therapeutics Founders and Leadership Team
Contact details for the ViAqua Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →ViAqua Therapeutics Funding Compared to Other Biotechnology Startups
ViAqua Therapeutics' latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ViAqua Therapeutics in Biotechnology and Misgav
Companies Similar to ViAqua Therapeutics
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
ViAqua Therapeutics Funding FAQs
What does ViAqua Therapeutics do?
ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotech experience.
How much funding has ViAqua Therapeutics raised?
ViAqua Therapeutics has raised $4.3M across 1 round on record. The most recent is an undisclosed round of $4.3M announced in Jun 2021.
When did ViAqua Therapeutics last raise funding?
ViAqua Therapeutics' most recent funding round on record is an undisclosed round of $4.3M, announced in Jun 2021.
Who is the CEO of ViAqua Therapeutics?
Shai Ufaz is listed as CEO at ViAqua Therapeutics.
Where is ViAqua Therapeutics headquartered?
ViAqua Therapeutics is based in Misgav, Hazafon, Israel.
How many employees does ViAqua Therapeutics have?
ViAqua Therapeutics is in the 11-50 employee band.
How does ViAqua Therapeutics' funding compare to other Biotechnology startups?
ViAqua Therapeutics' latest round of $4.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ViAqua Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ViAqua Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.